Filter Results:
(556)
Show Results For
- All HBS Web
(556)
- People (4)
- News (149)
- Research (350)
- Events (2)
- Multimedia (4)
- Faculty Publications (168)
Show Results For
- All HBS Web
(556)
- People (4)
- News (149)
- Research (350)
- Events (2)
- Multimedia (4)
- Faculty Publications (168)
- Web
Blavatnik Fellowship in Life Science Entrepreneurship - Health Care
engineering, which became Abata Therapeutics. He founded the nonprofit biotechnology incubator Sling Health during his MD/PhD at Washington University in St. Louis. Steve holds a master's in drug development... View Details
- Web
Curriculum - Case Method Project
of the Democratic Party; political career of Martin Van Buren; bank chartering system; Panic of 1837; Democrats vs. Whigs; free banking Property, Suffrage, and the "Right of Revolution" in Rhode Island, 1842 This case explores the View Details
- 23 Mar 2020
- Research & Ideas
Product Disasters Can Be Fertile Ground for Innovation
including a 20-article investigative series in the New York Times that discovered similar cases at other hospitals. The US Food and Drug Administration (FDA) started investigations of the CT devices, dozens of patients joined in a... View Details
- Research Summary
Clinical Trials as a setting for Health Policy and Management Research
The clinical trial marketplace is in flux. A decade ago, pharmaceutical firms almost exclusively conducted the study of their novel drug compounds within major academic medical centers. But today, industry-sponsored clinical trials are increasingly using community... View Details
- 21 Feb 2018
- Research & Ideas
When a Competitor Abandons the Market, Should You Advance or Retreat?
different markets but using the same technology. Among the findings: Companies were more than twice as likely to end development on a drug if a competitor in the same market using the same technology decided... View Details
- 05 Dec 2017
- First Look
First Look at New Research and Ideas, December 5, 2017
learning from parallel R&D projects in the setting of drug development. Leveraging the biopharmaceutical industry's unique characteristics to overcome barriers to measuring the project-level response to competitor news, I employ a... View Details
Keywords: Sean Silverthorne
- 29 Jun 2022
- Blog Post
Harvard Business School Announces the 2022-2023 Blavatnik Fellows
medicines. Hunter plans to use the Blavatnik Fellowship year to refine strategy and business development for the company’s novel drug delivery platform with his co-founders, Harvard Medical School Professor... View Details
- 01 Dec 2023
- News
Wide Horizon
making progress,” he acknowledges. “There’s no quarterly profits; there’s no ‘sell the company and count your money.’ ” “But there are some promising leads,” Rodakis says. Back when he started N of One, there was little in the ASD drug... View Details
Keywords: Dan Morrell; Photos by Sarah Wilson
- 08 Aug 2011
- Research & Ideas
The Death of the Global Manager
and its efforts to establish Humanitarian Assistance for Neglected Diseases (HAND), a corporate social responsibility program focused on treatments for diseases that typically affect too small a population to warrant the attention of drug... View Details
Keywords: by Julia Hanna
- Web
Policies, Rules & Guidelines | About
flights; the purpose of this policy is to help clarify acceptable use and safety of UAS on or above the HBS campus. Drug & Alcohol Policy Harvard Business School’s policy on drugs and alcohol reflects our... View Details
- 16 Dec 2014
- First Look
First Look: December 16
more or less effective. We develop these ideas in a multi-method study of a hospital emergency department (ED) redesign. Before the redesign, people coordinated in ad-hoc groupings, which provided flexibility because any nurse could work... View Details
Keywords: Sean Silverthorne
- 22 Feb 2024
- News
Combat-Tested Cancer Coaching
Subscribe on iTunes Subscribe on Spotify More Skydeck episodes Hi, this is Dan Morrell, host of Skydeck. When Kathy Giusti (MBA 1985) was diagnosed with multiple myeloma in 1996, she was overwhelmed. It was the pre-Internet era, with limited available information, but... View Details
- 25 Jul 2023
- Research & Ideas
Could a Business Model Help Big Pharma Save Lives and Profit?
With Hepatitis C running rampant in Egypt in 2012, Clifford Samuel, then of California-based Gilead Sciences, convened a series of urgent meetings with Egyptian government officials, doctors, and patients. His goal? To make Gilead’s lifesaving Hepatitis C View Details
- Web
Profiles - MBA
biomaterials, drug design and delivery, healthcare, early-stage venture capital Formative experience at the intersection of technology and business Working closely on translating technology I help develop... View Details
- 18 Jul 2024
- Blog Post
Harvard Business School Announces Its 2024-2025 Blavatnik Fellows
which became Abata Therapeutics. He founded the nonprofit biotechnology incubator Sling Health during his MD/PhD at Washington University in St. Louis. Steve holds a master's in drug development from the... View Details
- 01 Sep 2023
- News
Solving for Z
consistent with external survey results that demonstrate a lack of such alignment is one of the key reasons cited for wanting to leave a current position.) For example, when Adobe began developing a new family of generative AI models... View Details
- 07 Feb 2024
- News
The Sound of Success
A groundbreaking gene therapy developed by Akouos, Inc., a precision genetic medicine company founded in 2016 by Emmanuel (Manny) Simons (MBA 2012), has enabled an 11-year-old boy from Morocco to hear sounds for the first time. According... View Details
- 27 Jan 2003
- Research & Ideas
New Cluster Mapping Project Helps Companies Locate Facilities
economic development decisions to a new level of sophistication. In a cluster, a company can draw on a local supplier base of skilled people, specialized service providers, and local institutions that can provide training and perform... View Details
Keywords: by Sean Silverthorne
- 23 Mar 2010
- First Look
First Look: March 23
Publications "From Visible Harm to Relative Risk: Centralization and Fragmentation of Pharmacovigilance Author: Arthur A. Daemmrich Publication: Chap. 13 in The Fragmentation of U.S. Health Care, Oxford University Press, 2010 Abstract Adverse View Details
Keywords: Martha Lagace
- 14 Jul 2023
- Blog Post
Harvard Business School Announces Its 2023-2024 Blavatnik Fellows
industries, including: a novel enzymatic RNA synthesis platform, an immune system-driven dendritic cell therapy to combat cancer, new molecular technologies for the delivery of transdermal formulations, a lipid-targeting drug to treat... View Details